Improvement of Pulmonary Function After Implementation of a Standardized Cystic Fibrosis Care Algorithm
Bacterial infections and the antibiotics prescribed for children with cystic fibrosis-related pulmonary exacerbations
How long after treatment do people with cystic fibrosis no longer have Burkholderia cepacia complex in their sputum samples?
Using Home Spirometry Devices to Watch Over Children with Cystic Fibrosis: Can It Help Detect and Treat Pulmonary Exacerbations and Improve 1-Year Lung Function?
Changes in pancreatic enzyme function for children with cystic fibrosis while taking modulators (Trikafta®, Orkambi®, Symdeco®, and Kalydeco®)
Making the diagnosis of nontuberculous mycobacteria (NTM) lung disease standard with the PREDICT study
Comparing how effective and safe 14 days and 28 days of inhaled aztreonam were at getting rid of a Pseudomonas bacterial lung infection.
STOP Codon mutations are associated with more severe disease from childhood in people with cystic fibrosis
